Skip to Main Content

Paper Details

Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness study.
J Int AIDS Soc
13
2022
Author NameAffiliation
Maggie Czarnogorski
Leandro MenaUniversity of Mississippi Medical Center
Jason FlammKaiser Permanente Sacramento
  • 1 - 3

Datasets

Release 1.2